Haptoglobin phenotype and abnormal uterine artery Doppler in a racially diverse cohort

References

• Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004;18:383–96
   PubMed Web of Science ®Google Scholar
• North RA, McCowan LM, Dekker GA, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ;342:d1875
   Google Scholar
• Yu CK, Smith GC, Papageorghiou AT, et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005;193:429–36
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Sutherland GR, Liberati M, et al. Prevalence of maternal cardiac defects in women with high-resistance uterine artery Doppler indices. Ultrasound Obstet Gynecol 2011;37:310–16
   Google Scholar
• Acacio GL. Uterine artery Doppler patterns in abdominal pregnancy. Ultrasound Obstet Gynecol 2002;20:194–6
   Google Scholar
• Fraser R, Whitley GS, Johnstone AP, et al. Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance. J Pathol 2012;228:322–32
   PubMed Web of Science ®Google Scholar
• Prefumo F, Sebire NJ, Thilaganathan B. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod 2004;19:206–9
   PubMed Web of Science ®Google Scholar
• Myatt L, Clifton RG, Roberts JM, et al. The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstetr Gynecol 2012;120:815–22
   PubMed Web of Science ®Google Scholar
• Levy AP, Asleh R, Blum S, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal12:293–304
   Google Scholar
• Cid MC, Grant DS, Hoffman GS, et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977–85
   Google Scholar
• Herrler A, Krusche CA, Muller-Schottle F, Beier HM. Haptoglobin expression and release by rabbit oviduct and endometrium, its localization in blastocyst extra-embryonic matrix and fluid during preimplantation time. Hum Reprod 2004;19:2730–7
   Google Scholar
• Herrler A, von Rango U, Beier HM. Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation. Reprod Biomed Online 2003;6:244–56
   PubMedGoogle Scholar
• Frand J, Borislavsky A, Boaz M, et al. Does adiponectin level explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients? Atherosclerosis 2013;226:146–8
   Google Scholar
• Shor M, Boaz M, Gavish D, et al. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus. Am J Cardiol 2007;100:1767–70
   Google Scholar
• Nauta U, Beier HM, Herrler A. Abstract: haptoglobin in extracellular matrices reduce the adhesion/invasion of NK (CD11b+) cells. Reprod Abstracts Ser 2002;29:21
   Google Scholar
• Levy AP, Hochberg I, Jablonski K, et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the Strong Heart Study. J Am Coll Cardiol 2002;40:1984–90
   PubMed Web of Science ®Google Scholar
• Sammour RN, Nakhoul FM, Levy AP, et al. Haptoglobin phenotype in women with preeclampsia. Endocrine 2010;38:303–8
   Google Scholar
• Weissgerber TL, Roberts JM, Jeyabalan A, et al. Haptoglobin phenotype, angiogenic factors, and preeclampsia risk. Am J Obstet Gynecol 2012;206:358 e310–18
   Web of Science ®Google Scholar
• Mustafa S, Vukovich T, Prikoszovich T, et al. Haptoglobin phenotype and gestational diabetes. Diabetes Care 2004;27:2103–7
   Google Scholar
• Cho JK, Kim YH, Park IY, et al. Polymorphism of haptoglobin in patients with premature rupture of membrane. Yonsei Med J 2009;50:132–6
   Google Scholar
• Weissgerber TL, Gandley RE, McGee PL, et al. Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population. PLoS One 2013;8:e60479
   Google Scholar
• Weissgerber TL, Gandley RE, Roberts JM, et al. Haptoglobin phenotype and preeclampsia incidence in women with Type 1 Diabetes supplemented with Vitamins C and E. Brit J Obstetr Gynecol 2013;120:1192–9
   Google Scholar
• Goldenstein H, Levy N, Levy A. Involvement of haptoglobin in prevention of oxidative stress caused by hemoglobin in preeclampsia. Adv Biosci Biotechnol 2012;3:1037–42
   Google Scholar
• Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010;362:1282–91
   PubMed Web of Science ®Google Scholar
• Gaensslen RE, Bell SC, Lee HC. Distributions of genetic markers in United States populations: III. Serum group systems and hemoglobin variants. J Forensic Sci 1987;32:1754–74
   Google Scholar
• Langlois MR, Delanghe JR, De Buyzere ML, et al. Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr 1997;66:606–10
   PubMed Web of Science ®Google Scholar
• Berkova N, Lemay A, Dresser DW, et al. Haptoglobin is present in human endometrium and shows elevated levels in the decidua during pregnancy. Mol Hum Reprod 2001;7:747–54
   PubMed Web of Science ®Google Scholar
• Cheng TM, Pan JP, Lai ST, et al. Immunochemical property of human haptoglobin phenotypes: determination of plasma haptoglobin using type-matched standards. Clin Biochem 2007;40:1045–56
   PubMed Web of Science ®Google Scholar
• Depypere HT, Langlois MR, Delanghe JR, et al. Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med 2006;44:924–8
   Google Scholar
• Raijmakers MT, Roes EM, te Morsche RH, et al. Haptoglobin and its association with the HELLP syndrome. J Med Genet 2003;40:214–16
   Google Scholar